Erna Elise Paulsen
Stillingsbeskrivelse
Kreftforsker og onkolog, medlem i Translational Cancer Research Group (TCRG) ved Institutt for Klinisk Medisin.
https://uit.no/research/tcrg
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Ana Paola Lombardi,
Irene D’arsiè,
Erna-Elise Paulsen
m.fl.:
Prognostic impact of miR-17-5p and miR-20a-5p in NSCLC diverge in subgroups according to lymph node status
Dagny Førde,
Thomas Karsten Kilvær,
Mona Irene Pedersen,
Egil Støre Blix,
Ilona Halva Urbarova,
Erna-Elise Paulsen
m.fl.:
High density of TCF1+ stem-like tumor-infiltrating lymphocytes is associated with favorable disease-specific survival in NSCLC
Anna Gullhaug,
Vilde Drageset Haakensen,
Dirk De Ruysscher,
Charles B. Simone,
Alexandra E. Hotca-Cho,
Arpit M. Chhabra
m.fl.:
Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Mona Irene Pedersen,
Ana Paola Lombardi,
Mette Pøhl
m.fl.:
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
Mehrdad Rakaee,
Sigve Andersen,
K. Giannikou,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Lill-Tove Rasmussen Busund
m.fl.:
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Ilona Halva Urbarova,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
m.fl.:
Increased levels of microRNA-320 in blood serum and plasma is associated with imminent and advanced lung cancer
Sissel Gyrid Freim Wahl,
Yan Dai Hong,
Elisabeth Fritzke Emdal,
Thomas Berg,
Tarje Onsøien Halvorsen,
Anine Larsen Ottestad
m.fl.:
The prognostic effect of KRAS mutations in non-small cell lung carcinoma revisited: A norwegian multicentre study
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Simin Jamaly,
Thomas Berg,
Erna-Elise Paulsen,
Marte Berglund
m.fl.:
Tertiary lymphoid structure score: a promising approach to refine the TNM staging in resected non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigve Andersen,
Mehrdad Rakaee,
Roy M. Bremnes,
Lill-Tove Rasmussen Busund
m.fl.:
Digitally quantified CD8+ cells: the best candidate marker for an immune cell score in non-small cell lung cancer?
Mehrdad Rakaee,
Lill-Tove Busund,
Simin Jamaly,
Erna-Elise Paulsen,
Elin Richardsen,
Sigve Andersen
m.fl.:
Prognostic Value of Macrophage Phenotypes in Resectable Non–Small Cell Lung Cancer Assessed by Multiplex Immunohistochemistry
Kaja Konstanse Skjefstad,
Charles Johannessen,
Thea K.W. Grindstad,
Thomas Karsten Kilvær,
Erna Elise Paulsen,
Mona Irene Pedersen
m.fl.:
A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer
Mehrdad Rakaee,
Thomas Karsten Kilvær,
Stig Manfred Dalen,
Elin Richardsen,
Erna Elise Paulsen,
Sigurd Hald
m.fl.:
Evaluation of tumor-infiltrating lymphocytes using routine H&E slides predicts patient survival in resected non-small cell lung cancer
Sigurd Hald,
Mehrdad Rakaee,
Inigo Zubiavrre Martinez,
Elin Richardsen,
Samer Al-Saad,
Erna Elise Paulsen
m.fl.:
LAG-3 in Non-Small-cell Lung Cancer: Expression in Primary Tumors and Metastatic Lymph Nodes Is Associated With Improved Survival
Nora Ness,
Sigve Andersen,
Mehrdad Rakaee,
Cecilie Nordbakken,
Andrey Yurjevich Valkov,
Erna-Elise Paulsen
m.fl.:
The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Elin Richardsen,
Sigurd Hald,
Sigve Andersen
m.fl.:
CTLA-4 expression in the non-small cell lung cancer patient tumor microenvironment: diverging prognostic impact in primary tumors and lymph node metastases
Roy M. Bremnes,
Lill-Tove Busund,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen
m.fl.:
The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer
Tom Dønnem,
Thomas Karsten Kilvær,
Sigve Andersen,
Elin Richardsen,
Erna-Elise Paulsen,
Sigurd Hald
m.fl.:
Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer
Mehrdad Rakaee,
Lill-Tove Busund,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Sigve Andersen
m.fl.:
Prognostic effect of intratumoral neutrophils across histological subtypes of non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaee,
Samer Al-Saad,
Sigurd Hald,
Sigve Andersen
m.fl.:
Assessing PDL-1 and PD-1 in non-small cell lung cancer: a novel immunoscore approach
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Mehrdad Rakaee,
Samer Al-Saad,
Ramona Johansen Maurseth,
Khalid Al-Shibli
m.fl.:
The presence of intraepithelial CD45RO+ cells in resected lymph nodes with metastases from NSCLC patients is an independent predictor of disease-specific survival
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Turid Hellevik,
Samer Al-Saad,
Erna-Elise Paulsen,
Roy M. Bremnes
m.fl.:
Cancer associated fibroblasts in stage I-IIIA NSCLC: Prognostic impact and their correlations with tumor molecular markers
Tom Dønnem,
Sigurd Hald,
Erna-Elise Paulsen,
Elin Richardsen,
Samer Al-Saad,
Thomas Karsten Kilvær
m.fl.:
Stromal CD8+ T-cell density - A promising supplement to TNM staging in non-small cell lung cancer
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Mehrdad Rakaeekhanehkenari,
Ramona Johansen Maurseth,
Samer Al-Saad,
Sigurd Hald
m.fl.:
CD45RO+ memory T lymphocytes – a candidate marker for TNM-immunoscore in squamous non-small cell lung cancer
Thomas Karsten Kilvær,
Erna-Elise Paulsen,
Sigurd Hald,
Tom Wilsgaard,
Roy M. Bremnes,
Lill-Tove Busund
m.fl.:
Lymphangiogenic markers and their impact on nodal metastasis and survival in non-small cell lung cancer - A structured review with meta-analysis
Masoud Tafavvoghi,
Erna-Elise Paulsen,
Falah Jabar Rahim,
Sigve Andersen,
Ana Paola Lombardi,
Elin Richardsen
m.fl.:
51P Deep learning-based detection of non-angiogenic growth patterns in early-stage lung cancer
Per Niklas Benzler Waaler,
Magdalena Solveig Robertsen,
Erna-Elise Paulsen,
Sigve Andersen,
Elin Richardsen,
Åslaug Helland
m.fl.:
21P Integration of genomic and clinical data for relapse prediction in early-stage non-small cell lung cancer
Masoud Tafavvoghi,
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
A. Cortellini,
P. Lombardi
m.fl.:
219P Benchmarking state-of-the-art deep learning models for tumor-infiltrating lymphocytes (TILs) quantification
Mehrdad Rakaee,
Per Niklas Benzler Waaler,
Falah Jabar Rahim,
Krinio Giannikou,
Elio Adib,
Sigve Andersen
m.fl.:
Abstract 5366: DRAGEN pipeline validation for somatic variant detection in diagnostics using TSO500 panel
M.S. Robertsen,
Per Niklas Benzler Waaler,
Sigve Andersen,
Erna-Elise Paulsen,
Thomas Karsten Kilvær,
Sissel Gyrid Freim Wahl
m.fl.:
1802P Tissue tumor mutational burden and risk of recurrence in early-stage non-small cell lung cancer
Mehrdad Rakaee,
Masoud Tafavvoghi,
A. Cortellini,
Sigve Andersen,
Falah Jabar Rahim,
L. Brunetti
m.fl.:
P1.11.62 Deep Learning Histopathology Model for PD-L1 (TPS) and Immunotherapy Outcome Prediction in Non-Small Cell Lung Cancer
Odd Terje Brustugun,
Bjørn Henning Grønberg,
Marianne Aanerud,
Erna-Elise Paulsen,
Lars Fjellbirkeland
:
Lung Cancer in Norway
Falah Jabar Rahim,
Sigve Andersen,
Erna-Elise Paulsen,
Masoud Tafavvoghi,
Elin Helmine Richardsen,
Sissel Gyrid Freim Wahl
m.fl.:
Integrating Artificial intelligence (AI)-based lymphocytic infiltration assessment in early-stage NSCLC: A sub-study of the TNM-I trial
Ilona H. Urbarova,
Therese Haugdahl Nøst,
Anne Heidi Skogholt,
Robin Mjelle,
Erna-Elise Paulsen,
Tom Dønnem
m.fl.:
Increased Levels of mRNAs and miRNAs Associated with Imminent and Advanced Lung Cancer
Oda G Rikardsen Leknessund,
Erna-Elise Paulsen,
Tor Ingebrigtsen
:
Hvilke nye behandlinger av glioblastom planlegges utprøvd?
Hjerne det! 2021 ARKIV
Odd Terje Brustugun,
Sveinung Sørhaug,
Bjørn Henning Grønberg,
Marianne Aanerud,
Mohammed Modar Al-Zubaydi,
Lars Fjellbirkeland
m.fl.:
Lungekreft: Forbedret prognose gir kapasitetsutfordringer
De 50 siste resultatene vises på siden. Se alle arbeider i NVA her →
Forskningsinteresser
Hovedfokus på translasjonell og klinisk lungekreftforskning.
Arbeider med kliniske studier som lungeonkolog ved Lungemedisinsk avdeling v/UNN Tromsø.
Undervisning
Undervisning i onkologi for medisin- og sykepleierstudenter.